Pathophysiology of obsessive-compulsive disorder: Insights from Normal function and neurotoxic effects of drugs, infection, and brain injury

Handbook of Neurotoxicity

Volumn 3, Issue , 2014, Pages 2231-2253

  Szechtman, Henry ^a   Shivji, Sohel ^a   Woody, Erik Z ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927796540     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-5836-4_118     Document Type: Chapter

References (123)

1. Adler, C. M., McDonough-Ryan, P., Sax, K. W., Holland, S. K., Arndt, S., & Strakowski, S. M. (2000). FMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. Journal of Psychiatric Research, 34(4-5), 317-324.
2. Ahlskog, J. E. (2011). Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease. Physiology & Behavior, 104(1), 168-172.
3. Aldridge, J. W., Berridge, K. C., & Rosen, A. R. (2004). Basal ganglia neural mechanisms of natural movement sequences. Canadian Journal of Physiology and Pharmacology, 82(8-9), 732-739.
4. Alegret, M., Junque, C., Valldeoriola, F., Vendrell, P., Marti, M. J., & Tolosa, E. (2001). Obsessive-compulsive symptoms in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 70(3), 394-396.
5. Alexander, G. E., Delong, M. R., & Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357-381.
6. American Psychiatric Association. Task Force on DSM-IV. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed.). Washington, DC: American Psychiatric Association.
7. Anderson, D., & Ahmed, A. (2003). Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation. Case report. Journal of Neurosurgery, 98(5), 1104-1108.
8. Aouizerate, B., Cuny, E., Martin-Guehl, C., Guehl, D., Amieva, H., Benazzouz, A., Fabrigoule, C., Allard, M., Rougier, A., Bioulac, B., Tignol, J., & Burbaud, P. (2004). Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. Journal of Neurosurgery, 101(4), 682-686.
9. Arnold, P. D., Sicard, T., Burroughs, E., Richter, M. A., & Kennedy, J. L. (2006). Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Archives ofGeneral Psychiatry, 63(7), 769-776.
10. Baer, L., Rauch, S. L., Ballantine, H. T., Martuza, R., Cosgrove, R., Cassem, E., Giriunas, I., Manzo, P. A., Dimino, C., & Jenike, M. A. (1995). Cingulotomy for intractable obsessive- compulsive disorder - Prospective long-term follow-up of 18 patients. Archives of General Psychiatry, 52, 384-392.
11. Barnes, D. S. (2000). Historical perspectives on the etiology of tuberculosis. Microbes and Infection, 2(4), 431-440.
12. Baxter, L. R., Jr. (1992). Neuroimaging studies of obsessive compulsive disorder. The Psychiatric Clinics of North America, 15(4), 871-884.
13. Baxter, L. R., Jr., Schwartz, J. M., Bergman, K. S., Szuba, M. P., Guze, B. H., Mazziotta, J. C., Alazraki, A., Selin, C. E., Ferng, H. K., & Munford, P. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry, 49(9), 681-689.
14. Bechara, A., Damasio, H., & Damasio, A. R. (2000). Emotion, decision making and the orbitofrontal cortex. Cerebral Cortex, 10(3), 295-307.
15. Benkelfat, C., Nordahl, T. E., Semple, W. E., King, A. C., Murphy, D. L., & Cohen, R. M. (1990). Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Archives of General Psychiatry, 47(9), 840-848.
16. Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V., Bracken, M. B., & Leckman, J. F. (2006). A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry, 11(7), 622-632.
17. Blundell, J. (1991). Pharmacological approaches to appetite suppression. Trends in Pharmacological Sciences, 12, 147-157.
18. Bode, L., Zimmermann, W., Ferszt, R., Steinbach, F., & Ludwig, H. (1995). Borna-disease virus genome transcribed and expressed in psychiatric-patients. Nature Medicine, 1 (3), 232-236.
19. Bourdy, R., & Barrot, M. A. (2012). A new control center for dopaminergic systems: Pulling the VTA by the tail. Trends in Neurosciences, 35(11), 681-690.
20. Bourne, S. K., Eckhardt, C. A., Sheth, S. A., & Eskandar, E. N. (2012). Mechanisms of deep brain stimulation for obsessive compulsive disorder: Effects upon cells and circuits. Frontiers in Integrative Neuroscience, 6, 29.
21. Boyer, P., & Bergstrom, B. (2011). Threat-detection in child development: An evolutionary perspective. Neuroscience and Biobehavioral Reviews, 35(4), 1034-1041.
22. Boyer, P., & Lienard, P. (2006). Why ritualized behavior? Precaution systems and action parsing in developmental, pathological and cultural rituals. The Behavioral and Brain Sciences, 29(6), 595-613.
23. Brown, R. G., & Pluck, G. (2000). Negative symptoms: The "pathology" of motivation and goal- directed behaviour. Trends in Neurosciences, 23(9), 412-417.
24. Chiocca, E. A., & Martuza, R. L. (1990). Neurosurgical therapy of obsessive-compulsive disorder. In M. A. Jenike, L. Baer, & W. E. Minichiello (Eds.), Obsessive-compulsive disorders: Theory and management (Vol. 2nd, pp. 283-294). Chicago: Year Book Medical Publishers.
25. Coetzer, B. R. (2004). Obsessive-compulsive disorder following brain injury: A review. International Journal of Psychiatry in Medicine, 34(4), 363-377.
26. Crum, R. M., & Anthony, J. C. (1993). Cocaine use and other suspected risk factors for obsessive- compulsive disorder: A prospective study with data from the Epidemiologic Catchment Area surveys. Drug and Alcohol Dependence, 31 (3), 281-295.
27. Cummings, J. L., & Cunningham, K. (1992). Obsessive-compulsive disorder in Huntington's disease. Biological Psychiatry, 31(3), 263-270.
28. da Rocha, F. F., Correa, H., & Teixeira, A. L. (2008). Obsessive-compulsive disorder and immunology: A review. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32(5), 1139-1146.
29. Davis, M., & Shi, C. (1999). The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Annals of the New York Academy of Sciences, 877, 281-291.
30. Davis, M., Walker, D. L., & Lee, Y. (1997). Amygdala and bed nucleus of the stria terminalis: Differential roles in fear and anxiety measured with the acoustic startle reflex. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 352(1362), 1675-1687.
31. De Carolis, L., Schepisi, C., Milella, M., Nencini, P. (2011). Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior. Psychopharmacology, 218(4), 749-759
32. Denys, D., Mantione, M., Figee, M., van den Munckhof, P., Koerselman, F., Westenberg, H., Bosch, A., & Schuurman, R. (2010). Deep brain stimulation of the nucleus acccumbens for treatment-refractory obsessive-compulsive disorder. Archives of General Psychiatry, 67(10), 1061-1068.
33. Denys, D., Zohar, J., & Westenberg, H. G. (2004). The role of dopamine in obsessive-compulsive disorder: Preclinical and clinical evidence. The Journal of Clinical Psychiatry, 65(Suppl 14), 11-17.
34. Desarkar, P., Das, A., & Nizamie, S. H. (2007). Aripiprazole-induced obsessive-compulsive disorder: A report of 2 cases. Journal ofClinical Psychopharmacology, 27(3), 305-306.
35. DeVeaugh-Geiss, J. (1994). Pharmacologic therapy of obsessive compulsive disorder. Advances in Pharmacology, 30, 35-52.
36. Dougherty, D. D., Baer, L., Cosgrove, G. R., Cassem, E. H., Price, B. H., Nierenberg, A. A., Jenike, M. A., & Rauch, S. L. (2002). Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. The American Journal of Psychiatry, 159(2), 269-275.
37. Dougherty, D. D., Rauch, S. L., & Jenike, M. A. (2004). Pharmacotherapy for obsessive- compulsive disorder. Journal of Clinical Psychology, 60(11), 1195-1202.
38. Dvorkin, A., Silva, C., McMurran, T., Bisnaire, L., Foster, J., & Szechtman, H. (2010). Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex. The European Journal of Neuroscience, 32(9), 1552-1563.
39. Eisen, J. L., Leonard, H. L., Swedo, S. E., Price, L. H., Zabriskie, J. B., Chiang, S. Y., Karitani, M., & Rasmussen, S. A. (2001). The use of antibody D8/17 to identify B cells in adults with obsessive-compulsive disorder. Psychiatry Research, 104(3), 221-225.
40. Ercan, T. E., Ercan, G., Severge, B., Arpaozu, M., & Karasu, G. (2008). Mycoplasma pneumoniae infection and obsessive-compulsive disease: A case report. Journal of Child Neurology, 23(3), 338-340.
41. Everitt, B. J., & Wolf, M. E. (2002). Psychomotor stimulant addiction: A neural systems perspective. The Journal of Neuroscience, 22(9), 3312-3320.
42. Fessler, D. M. (2001). Luteal phase immunosuppression and meat eating. Rivista di Biologia, 94(3), 403-426.
43. Fiddick, L. (2011). There is more than the amygdala: Potential threat assessment in the cingulate cortex. Neuroscience and Biobehavioral Reviews, 35(4), 1007-1018.
44. Fontaine, D., Mattei, V., Borg, M., von Langsdorff, D., Magnie, M. N., Chanalet, S., Robert, P., & Paquis, P. (2004). Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report. Journal of Neurosurgery, 100(6), 1084-1086.
45. Friedlander, L., & Desrocher, M. (2006). Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clinical Psychology Review, 26(1), 32-49.
46. Ghahremani, D. G., Lee, B., Robertson, C. L., Tabibnia, G., Morgan, A. T., De Shetler, N., Brown, A. K., Monterosso, J. R., Aron, A. R., Mandelkern, M. A., Poldrack, R. A., & London, E. D. (2012). Striatal dopamine D2/D3 receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. The Journal of Neuroscience, 32(21), 7316-7324.
47. Glickman, S. E., & Schiff, B. B. (1967). A biological theory of reinforcement. Psychological Review, 74(2), 81-109.
48. Groenewegen, H. J., Wright, C. I., Beijer, A. V. J., & Voorn, P. I. E. (1999). Convergence and segregation of ventral striatal inputs and outputs. Annals of the New York Academy of Sciences, 877(1), 49-63.
49. Haber, S. N., Fudge, J. L., & McFarland, N. R. (2000). Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. The Journal of Neuroscience, 20(6), 2369-2382.
50. Haynes, W. I. A., & Mallet, L. (2010). High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: The search for a valid circuit. The European Journal of Neuroscience, 32(7), 1118-1127.
51. Hebb, D. O. (1966). A Textbook of Psychology (Vol. 2D). Philadelphia: Saunders.
52. Hoffman, K. L., & Rueda Morales, R. I. (2012). D1 and D2 dopamine receptor antagonists decrease behavioral bout duration, without altering the bout's repeated behavioral components, in a naturalistic model of repetitive and compulsive behavior. Behavioural Brain Research, 230(1), 1-10.
53. Huff, W., Lenartz, D., Schormann, M., Lee, S. H., Kuhn, J., Koulousakis, A., Mai, J., Daumann, J., Maarouf, M., Klosterkotter, J., & Sturm, V. (2010). Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clinical Neurology and Neurosurgery, 112(2), 137-143.
54. Huoranszki, F. (2011). Weakness and compulsion: The essential difference. Philosophical Explorations, 14(1), 81-97.
55. Idro, R., Maling, S., & Byarugaba, J. (2005). Compulsive behavior and coprolalia after cerebral malaria. Journal of Pediatric Neurology, 3, 107-108.
56. Ikemoto, S., & Panksepp, J. (1999). The role of nucleus accumbens dopamine in motivated behavior: A unifying interpretation with special reference to reward-seeking. Brain Research Reviews, 31(1), 6-41.
57. Jenike, M. A., Baer, L., Ballantine, T., Martuza, R. L., Tynes, S., Giriunas, I., Buttolph, M. L., & Cassem, N. H. (1991). Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. Archives of General Psychiatry, 48(6), 548-555.
58. Joel, D., & Weiner, I. (2000). The connections of the dopaminergic system with the striatum in rats and primates: An analysis with respect to the functional and compartmental organization of the striatum. Neuroscience, 96(3), 451-474.
59. Kahneman, D. (2011). Thinking, Fast and Slow. Toronto: Doubleday Canada.
60. Kapadia, M., & Sakic, B. (2011). Autoimmune and inflammatory mechanisms of CNS damage. Progress in Neurobiology, 95(3), 301-333.
61. Kettl, P. A., & Marks, I. M. (1986). Neurological factors in obsessive compulsive disorder. Two case reports and a review of the literature. The British Journal of Psychiatry, 149, 315-319.
62. Kim, J. J., Lee, M. C., Kim, J., Kim, I. Y., Kim, S. I., Hee, H. M., Chang, K. H., & Kwon, J. S. (2001). Grey matter abnormalities in obsessive-compulsive disorder: Statistical parametric mapping of segmented magnetic resonance images. The British Journal of Psychiatry, 179, 330-334.
63. Kostrzewa, R. M. (1995). Dopamine receptor supersensitivity. Neuroscience and Biobehavioral Reviews, 19, 1-17.
64. Kurlan, R. (2004). Disabling repetitive behaviors in Parkinson's disease. Movement Disorders, 19(4), 433-437.
65. Lang, P. J., Davis, M., & Ohman, A. (2000). Fear and anxiety: Animal models and human cognitive psychophysiology. Journal of Affective Disorders, 61(3), 137-159.
66. Laplane, D., Levasseur, M., Pillon, B., Dubois, B., Baulac, M., Mazoyer, B., Tran, D. S., Sette, G., Danze, F., & Baron, J. C. (1989). Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. Brain, 112(Pt 3), 699-725.
67. LeDoux, J. E. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23(1), 155-184.
68. Lorrain, D. S., Riolo, J. V., Matuszewich, L., & Hull, E. M. (1999). Lateral hypothalamic serotonin inhibits nucleus accumbens dopamine: Implications for sexual satiety. The Journal of Neuroscience, 19(17), 7648-7652.
69. Lykouras, L. (2003). Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27(3), 333-346.
70. MacLean, P. D. (1973). Special award lecture: new findings on brain function and sociosexual behavior. In J. Zubin & J. Money (Eds.), Contemporary sexual behavior: Critical issues in the 1970s (pp. 53-74). Baltimore: The John Hopkins University Press.
71. MacLean, P. D. (1978). Effects of lesions of globus pallidus on species-typical display behavior of squirrel monkeys. Brain Research, 149(1), 175-196.
72. Mallet, L., Mesnage, V., Houeto, J. L., Pelissolo, A., Yelnik, J., Behar, C., Gargiulo, M., Welter, M. L., Bonnet, A. M., Pillon, B., Cornu, P., Dormont, D., Pidoux, B., Allilaire, J. F., & Agid, Y. (2002). Compulsions, Parkinson's disease, and stimulation. Lancet, 360(9342), 1302-1304.
73. Marchesi, C., Tonna, M., & Maggini, C. (2009). Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse. The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry, 10(4 Pt 2), 599-602.
74. Masterson, F. A., & Crawford, M. (1982). The defense motivation system - A theory of avoidance- behavior. The Behavioral and Brain Sciences, 5(4), 661-675.
75. Mataix-Cols, D., Wooderson, S., Lawrence, N., Brammer, M. J., Speckens, A., & Phillips, M. L. (2004). Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Archives of General Psychiatry, 61(6), 564-576.
76. McGuire, P. K., Bench, C. J., Frith, C. D., Marks, I. M., Frackowiak, R. S., & Dolan, R. J. (1994). Functional anatomy of obsessive-compulsive phenomena. The British Journal of Psychiatry, 164(4), 459-468.
77. Menzies, L., Chamberlain, S. R., Laird, A. R., Thelen, S. M., Sahakian, B. J., & Bullmore, E. T. (2008). Integrating evidence from neuroimaging and neuropsychological studies of obsessive- compulsive disorder: The orbitofronto-striatal model revisited. Neuroscience and Biobehavioral Reviews, 32(3), 525-549.
78. Mink, J. W. (1996). The basal ganglia: Focused selection and inhibition of competing motor programs. Progress in Neurobiology, 50(4), 381-425.
79. Muris, P., Merckelbach, H., & Clavan, M. (1997). Abnormal and normal compulsions. Behaviour Research and Therapy, 35(3), 249-252.
80. Nikolaus, S., Antke, C., Beu, M., & Muller, H. W. (2010). Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders-results from in vivo imaging studies. Reviews in the Neurosciences, 21(2), 119-139.
81. Nuttin, B., Cosyns, P., Demeulemeester, H., Gybels, J., & Meyerson, B. (1999). Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet, 354(9189), 1526.
82. Nuttin, B. J., Gabriels, L. A., Cosyns, P. R., Meyerson, B. A., Andreewitch, S., Sunaert, S. G., Maes, A. F., Dupont, P. J., Gybels, J. M., Gielen, F., & Demeulemeester, H. G. (2003). Longterm electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery, 52(6), 1263-1272.
83. Pauls, D. L., Towbin, K. E., Leckman, J. F., Zahner, G. E., & Cohen, D. J. (1986). Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Archives of General Psychiatry, 43(12), 1180-1182.
84. Penney, J. B., Jr., & Young, A. B. (1983). Speculations on the functional anatomy of basal ganglia disorders. Annual Review of Neuroscience, 6, 73-94.
85. Phillips, M. L., & Mataix-Cols, D. (2004). Patterns of neural response to emotive stimuli distinguish the different symptom dimensions of obsessive-compulsive disorder. CNS Spectrums, 9(4), 275-283.
86. Piasecki, S. D., & Jefferson, J. W. (2004). Psychiatric complications of deep brain stimulation for Parkinson's disease. The Journal of Clinical Psychiatry, 65(6), 845-849.
87. Pittenger, C., Bloch, M. H., & Williams, K. (2011). Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment. Pharmacology & Therapeutics, 132(3), 314-332.
88. Rachman, S., & De Silva, P. (1978). Abnormal and normal obsessions. Behaviour Research and Therapy, 16(4), 233-248.
89. Rasmussen, S. A., & Eisen, J. L. (1992). The epidemiology and differential-diagnosis of obsessive-compulsive disorder. The Journal of Clinical Psychiatry, 53, 4-10.
90. Rassin, E., & Muris, P. (2007). Abnormal and normal obsessions: A reconsideration. Behaviour Research and Therapy, 45(5), 1065-1070.
91. Rauch, S. L., Jenike, M. A., Alpert, N. M., Baer, L., Breiter, H. C., Savage, C. R., & Fischman, A. J. (1994). Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Archives of General Psychiatry, 51(1), 62-70.
92. Reed, G. F. (1985). Obsessional experience and compulsive behaviour: A cognitive-structural approach. Orlando: Academic Press.
93. Rotge, J. Y., Aouizerate, B., Tignol, J., Bioulac, B., Burbaud, P., & Guehl, D. (2010). The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms. Neuroscience, 165(2), 408-417.
94. Rotge, J. Y., Guehl, D., Dilharreguy, B., Cuny, E., Tignol, J., Bioulac, B., Allard, M., Burbaud, P., & Aouizerate, B. (2008). Provocation of obsessive-compulsive symptoms: A quantitative voxel-based meta-analysis of functional neuroimaging studies. Journal of Psychiatry & Neuroscience, 33(5), 405-412.
95. Salkovskis, P. M., & Harrison, J. (1984). Abnormal and normal obsessions-a replication. Behaviour Research and Therapy, 22(5), 549-552.
96. Saxena, S., Brody, A. L., Schwartz, J. M., & Baxter, L. R. (1998). Neuroimaging and frontal- subcortical circuitry in obsessive-compulsive disorder. The British Journal of Psychiatry. Supplement, 35, 26-37.
97. Schilder, P. (1938). The organic background of obsessions and compulsions. The American Journal of Psychiatry, 94, 1397-1414.
98. Semple, S. J., Strathdee, S. A., Zians, J., McQuaid, J., & Patterson, T. L. (2011). Correlates of obsessive-compulsive disorder in a sample of HIV-positive, methamphetamine-using men who have sex with men. AIDS and Behavior, 15(6), 1153-1160.
99. Soubrie, P. (1986). Reconciling the role of central serotonin neurons in human and animal behavior. The Behavioral and Brain Sciences, 9, 319-364.
100. Sturm, V., Lenartz, D., Koulousakis, A., Treuer, H., Herholz, K., Klein, J. C., & Klosterkotter, J. (2003). The nucleus accumbens: A target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. Journal of Chemical Neuroanatomy, 26(4), 293-299.
101. Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., Dow, S., Zamkoff, J., Dubbert, B. K., & Lougee, L. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. The American Journal of Psychiatry, 155(2), 264-271.
102. Swedo, S. E., Leonard, H. L., Mittleman, B. B., Allen, A. J., Rapoport, J. L., Dow, S. P., Kanter, M. E., Chapman, F., & Zabriskie, J. (1997). Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. The American Journal of Psychiatry, 154(1), 110-112.
103. Swedo, S. E., Pietrini, P., Leonard, H. L., Schapiro, M. B., Rettew, D. C., Goldberger, E. L., Rapoport, S. I., Rapoport, J. L., & Grady, C. L. (1992). Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Archives of General Psychiatry, 49(9), 690-694.
104. Swedo, S. E., Rapoport, J. L., Cheslow, D. L., Leonard, H. L., Ayoub, E. M., Hosier, D. M., & Wald, E. R. (1989). High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. The American Journal of Psychiatry, 146(2), 246-249.
105. Szechtman, H., Culver, K., & Eilam, D. (1999). Role of dopamine systems in obsessive- compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model. Polish Journal of Pharmacology, 51(1), 55-61.
106. Szechtman, H., Nahmias, C., & Woody, E. Z. (2002). Alucinaciones, compulsiones y "yedasentience": hacia una biologia de la epistemologia (hallucinations, compulsions and "yedasentience": Toward a biology of epistemology). In T. Palomo, R. J. Beninger, M. A. Jimenez Arriero, E. Huertas, & T. Archer (Eds.), Avances neurocientíficos y realidad clínica V, neuroimagen en psiquiatria (1st ed., pp. 173-194). Madrid: Fundacion Cerebro y Mente.
107. Szechtman, H., Sulis, W., & Eilam, D. (1998). Quinpirole induces compulsive checking behavior in rats: A potential animal model of obsessive-compulsive disorder (OCD). Behavioral Neuroscience, 112(6), 1475-1485.
108. Szechtman, H., & Woody, E. (2004). Obsessive-compulsive disorder as a disturbance of security motivation. Psychological Review, 111(1), 111-127.
109. Szechtman, H., & Woody, E. Z. (2006). Obsessive-compulsive disorder as a disturbance of security motivation: Constraints on comorbidity. Neurotoxicity Research, 10(2), 103-112.
110. Tass, P. A., Klosterkotter, J., Schneider, F., Lenartz, D., Koulousakis, A., & Sturm, V. (2003). Obsessive-compulsive disorder: Development of demand-controlled deep brain stimulation with methods from stochastic phase resetting. Neuropsychopharmacology, 28(S1), S27-S34.
111. Toates, F. M. (1986). Motivational systems. Cambridge Cambridgeshire: Cambridge University Press.
112. van den Heuvel, O. A., Veltman, D. J., Groenewegen, H. J., Dolan, R. J., Cath, D. C., Boellaard, R., Mesina, C. T., van Balkom, A. J., van Oppen, P., Witter, M. P., Lammertsma, A. A., & van Dyck, R. (2004). Amygdala activity in obsessive-compulsive disorder with contamination fear: A study with oxygen-15 water positron emission tomography. Psychiatry Research, 132(3), 225-237.
113. Westenberg, H. G., Fineberg, N. A., & Denys, D. (2007). Neurobiology of obsessive-compulsive disorder: Serotonin and beyond. CNS Spectrums, 12(2 Suppl 3), 14-27.
114. Wise, S., & Rapoport, J. L. (1989). Obsessive compulsive disorder - Is it a basal ganglia dysfunction? In J. Rapoport (Ed.), Obsessive compulsive disorder in children and adolescence (pp. 327-344). Washington, DC: American Psychiatric Press.
115. Wolgin, D. L. (2012). Amphetamine stereotypy, the basal ganglia, and the "selection problem". Behavioural Brain Research, 231 (2), 297-308.
116. Woody, E. Z., & Boyer, P. (2011). Threat-detection and precaution: Introduction to the special issue preface. Neuroscience and Biobehavioral Reviews, 35(4), 989-990.
117. Woody, E. Z., & Szechtman, H. (2000). Hypnotic hallucinations and yedasentience. Contemporary Hypnosis, 17, 26-31.
118. Woody, E. Z., & Szechtman, H. (2005). Motivation, time course, and heterogeneity in obsessive- compulsive disorder: Response to Taylor, McKay, and Abramowitz (2005). Psychological Review, 112(3), 658-661.
119. Woody, E. Z., & Szechtman, H. (2011). Adaptation to potential threat: The evolution, neurobiology, and psychopathology of the security motivation system. Neuroscience and Biobehavioral Reviews, 35(4), 1019-1033.
120. Woolf, C. J. (2011). Central sensitization: Implications for the diagnosis and treatment of pain. Pain, 152(3, Supplement), S2-S15.
121. Woolley, J. B., & Heyman, I. (2003). Dexamphetamine for obsessive-compulsive disorder. The American Journal of Psychiatry, 160(1), 183.
122. Wu, M., Hanna, G. L., Rosenberg, D. R., & Arnold, P. D. (2012). The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacology, Biochemistry, and Behavior, 100(4), 726-735.
123. Yu, C.-H., Lee, M.-B., Tseng, M. M.-C., & Liao, S.-C. (2008). Obsessive-compulsive symptoms as a manifestation of neuropsychiatric systemic lupus erythematosus. Journal of the Formosan Medical Association, 107(1), 68-72.